Literature DB >> 3116060

Respiratory function and carbonic anhydrase inhibition.

P G Berthelsen1, J O Dich-Nielsen.   

Abstract

Acetazolamide (Diamox) induced carbonic anhydrase inhibition is an efficient means of eliminating surplus water and bicarbonate in the overhydrated and alkalotic patient. Previous studies have demonstrated an unexpected and unexplained increase in arterial and venous oxygenation during acute carbonic anhydrase inhibition. In the present investigation we assessed the effect of acetazolamide 15 mg kg-1 on pulmonary gas exchange in 10 critically ill, mechanically ventilated patients. Median arterial oxygen tension increased by 0.9 kPa and central venous oxygen tension and content by 16-18% and 6-8% respectively. The improved oxygenation could, however, not be attributed to an improved pulmonary oxygen exchange as both pulmonary venous admixture (Qs Qt-1) and physiological dead space ventilation (VD VT-1) increased. The increase in arterial oxygen tension can be explained by a rightward shift of the oxyhemoglobin dissociation curve due to the increased acidity of the blood during carbonic anhydrase inhibition (Bohr effect). Acetazolamide does not depress oxygen consumption, so the increase in central venous oxygen content probably reflects an improved cardiac performance. This could conceivably be mediated via sympathetic activation in response to acetazolamide induced carbon dioxide retention.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116060     DOI: 10.1007/bf00255787

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  22 in total

1.  A quantitative analysis of CO2 transport at rest and during maximal exercise.

Authors:  E R Swenson; T H Maren
Journal:  Respir Physiol       Date:  1978-11

2.  Carbonic anhydrase inhibition and cerebral venous blood gases and ions in man. Demonstration of increased oxygen availability to ischemic brain.

Authors:  F Gotoh; J S Meyer; M Tomita
Journal:  Arch Intern Med       Date:  1966-01

3.  Metabolic alkalosis complicating weaning from mechanical ventilation.

Authors:  T J Gallagher
Journal:  South Med J       Date:  1979-07       Impact factor: 0.954

4.  Respiratory and renal effects of a carbonic anhydrase inhibitor (diamox) on acid-base balance in normal man and in patients with respiratory acidosis.

Authors:  M GALDSTON
Journal:  Am J Med       Date:  1955-10       Impact factor: 4.965

5.  Can central venous blood replace mixed venous blood samples?

Authors:  J Tahvanainen; O Meretoja; P Nikki
Journal:  Crit Care Med       Date:  1982-11       Impact factor: 7.598

6.  Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen.

Authors:  S Vorstrup; L Henriksen; O B Paulson
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

7.  Cardiovascular performance and oxyhemoglobin dissociation after acetazolamide in metabolic alkalosis.

Authors:  P Berthelsen
Journal:  Intensive Care Med       Date:  1982       Impact factor: 17.440

8.  Acute effects of acetazolamide on cerebral blood flow in man.

Authors:  A Hauge; G Nicolaysen; M Thoresen
Journal:  Acta Physiol Scand       Date:  1983-02

9.  Sources of error and their correction in the measurement of carbon dioxide elimination using the Siemens-Elema CO2 Analyzer.

Authors:  R Fletcher; O Werner; L Nordström; B Jonson
Journal:  Br J Anaesth       Date:  1983-02       Impact factor: 9.166

10.  Oxygen uptake and carbon dioxide elimination after acetazolamide in the critically ill.

Authors:  P Berthelsen; I Gøthgen; B Husum; E Jacobsen
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

View more
  1 in total

1.  Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise.

Authors:  Amy M Jonk; Irene P van den Berg; I Mark Olfert; D Walter Wray; Tatsuya Arai; Susan R Hopkins; Peter D Wagner
Journal:  J Physiol       Date:  2007-01-11       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.